Cardiol Therapeutics Inc. is a leader in producing 100% pure pharmaceutical CBD and developing ground-breaking therapies for heart disease. The Company is focused on commercially launching the safest and most consistent CBD products for consumers and healthcare providers in the multi-billion-dollar medicinal cannabinoid markets.
Cardiol is utilizing nanotechnologies designed to deliver CBD and other anti-inflammatory drugs for the treatment of heart failure. Heart failure is a leading cause of death and hospitalization in North America, with associated healthcare costs exceeding US$30 billion annually in the U.S. alone.
IR Contact: Trevor Burns
IR Phone: 905-491-6791
Website: https://www.cardiolrx.com
